Skip to main content
. Author manuscript; available in PMC: 2006 Jul 24.
Published in final edited form as: Neurology. 2005 Jun 28;64(12):2069–2073. doi: 10.1212/01.WNL.0000165987.89198.65

Table 1.

Demographics

AD, n = 48 AD/LBP, n = 65 LBP, n = 22 Total, n = 135
Age at onset, mean 77.47 ± 7.34 74.77 ± 6.59 76.45 ± 5.34 75.99 ± 6.75
Sex, M/F 18/30 24/41 16/6 58/77
Intake MMSE 20.60 ± 3.87 20.68 ± 3.72 20.73 ± 3.81 20.66 ± 3.76
Education
 <HS 13 (0.27) 13 (0.20) 4 (0.18) 30 (0.22)
 HS 7 (0.15) 26 (0.40) 5 (0.23) 38 (0.28)
 >HS 27 (0.56) 26 (0.40) 13 (0.59) 66 (0.49)
Duration of disease 6.03 ± 2.62 6.81 ± 2.52 5.65 ± 2.23 6.16 ± 2.50
Braak stage 4.69 ± 0.59 4.88 ± 0.57 2.14 ± 0.77 4.36 ± 1.16

Sex = frequency of male and female patients; intake MMSE = initial Mini-Mental State Examination score out of 30; <HS = less than high school; HS = high school or equivalent; >HS = greater than high school; duration of disease = age at death minus age of onset; Braak stage = mean stage of neurofibrillary tangles.